Azimuth Capital Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Buy
401,847
+20,888
+5% +$556K 0.42% 82
2025
Q4
$9.49M Buy
380,959
+20,283
+6% +$511K 0.34% 105
2025
Q3
$9.19M Sell
360,676
-2,564
-0.7% -$63.3K 0.33% 103
2025
Q2
$8.8M Sell
363,240
-105,812
-23% -$2.47M 0.33% 113
2025
Q1
$11.9M Sell
469,052
-2,323
-0.5% -$60.8K 0.47% 61
2024
Q4
$12.5M Sell
471,375
-2,983
-0.6% -$80.9K 0.49% 60
2024
Q3
$13.7M Sell
474,358
-3,094
-0.6% -$90.3K 0.53% 51
2024
Q2
$13.4M Sell
477,452
-6,620
-1% -$182K 0.54% 51
2024
Q1
$13.4M Buy
484,072
+685
+0.1% +$19K 0.55% 55
2023
Q4
$13.9M Sell
483,387
-34,884
-7% -$1.05M 0.63% 55
2023
Q3
$17.2M Buy
518,271
+1,485
+0.3% +$52.5K 0.85% 34
2023
Q2
$19M Sell
516,786
-5,120
-1% -$199K 0.9% 25
2023
Q1
$21.3M Sell
521,906
-2,050
-0.4% -$88.5K 1.05% 17
2022
Q4
$26.8M Sell
523,956
-5,587
-1% -$268K 1.36% 8
2022
Q3
$23.2M Sell
529,543
-10,596
-2% -$515K 1.27% 13
2022
Q2
$28.3M Buy
+540,139
New +$27.5M 1.43% 9

Other funds holding PFE

Azimuth Capital Investment Management's PFE Position: Q1 2026 in Review

Azimuth Capital Investment Management increased its Pfizer (PFE) stake by 5.5% in Q1 2026, buying an estimated $556K and bringing the position to 401,847 shares worth $11.3M. The position accounts for 0.42% of the portfolio, ranked #82.

Azimuth Capital Investment Management first reported a position in PFE in Q2 2022 and has held it in 16 quarters since. The position peaked at $28.3M in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Azimuth Capital Investment Management held 401,847 shares of Pfizer worth $11.3M as of Q1 2026.
  • Azimuth Capital Investment Management bought 20,888 Pfizer shares in Q1 2026, an estimated $556K.
  • Pfizer made up 0.42% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #82 holding.
  • Azimuth Capital Investment Management first reported a position in Pfizer in Q2 2022 and has held it in 16 quarters since.
  • Azimuth Capital Investment Management's Pfizer position peaked at $28.3M in Q2 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.